{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:08:08Z","timestamp":1789427288736,"version":"build-2803163510"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Esophageal squamous cell carcinoma (ESCC) is a cancer that is common worldwide. Its morbidity and mortality rates remain high, seriously threatening human health. In the tumor microenvironment (TME), CD8+ T cells undergo a series of dynamic changes that have important implications for tumor progression and the efficacy of immunotherapy. Our research aims to construct novel molecular subtypes through the gene expression profiling of CD8+ T cells during differentiation and to predict the prognostic and therapeutic effects in ESCC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In the single-cell sequencing (scRNA-seq) analysis, we clustered and visualized cell subsets using the Seurat package, removed batch effects between samples using the Harmony package, and performed pseudo-time analysis of CD8+ T cells using the Monocle2 package. In the bulk-RNA analysis, non-negative matrix factorization (NMF) was applied to construct molecular subtypes, and the unique expression of molecular subtypes in prognostic assessment, biological processes, genomic variation, and immune microenvironment composition was explored. The drug sensitivity of different subtypes was further studied. The causal relationship between gene expression during CD8+ T cell differentiation and ESCC occurrence was inferred using Mendelian Randomization (MR) analysis. In addition, the biological functions of key genes were further explored by\n                      <jats:italic>in vitro<\/jats:italic>\n                      cellular experiments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Based on the genes during CD8+ T cell differentiation, we identified three molecular subtypes with different clinical outcomes. To ensure the robustness and reproducibility of the molecular subtypes, we used the GSE53625 cohort for validation. Among them, the C1 subtype showed higher genomic variation, and its patients had significantly worse prognoses than the C2 and C3 subtypes. It is worth noting that the C3 subtype exhibits an \u201cimmune-heat\u201d phenotype, which is accompanied by a large number of immune cell infiltrates, up-regulated immunological checkpoint molecules, and greater sensitivity to immune therapy. In addition, we have screened a series of potential therapeutic drugs, which provides strong support for future clinical translational research. Finally, the results of Mendelian randomization analysis indicated that the RHOB gene could increase the risk of ESCC development. In addition,\n                      <jats:italic>in vitro<\/jats:italic>\n                      cellular assays such as CCK-8, scratch assay and Transwell verified that RHOB could promote the proliferation, migration and invasion of ESCC cells\n                      <jats:italic>in vitro<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study constructed molecular subtypes related to CD8+ T cells and analyzed in depth the biological characteristics, genomic variation, and role of these three molecular subtypes in the tumor microenvironment and immunotherapy. These molecular subtypes allow us to more accurately identify patient groups and thus provide more effective treatment strategies for ESCC patients. In addition, this study identified RHOB as a novel biomarker for esophageal squamous cell carcinoma and verified that RHOB was associated with proliferation, migration and invasion of ESCC by\n                      <jats:italic>in vitro<\/jats:italic>\n                      cellular assays.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1775837","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:37:48Z","timestamp":1774593468000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The construction of CD8+ T cell-associated molecular subtypes in esophageal squamous cell carcinoma reveals tumor heterogeneity, tumor microenvironment, and immunotherapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Sinan","family":"Cao","sequence":"first","affiliation":[{"name":"Oncology Department, Henan University People\u2019s Hospital (Henan Provincial People\u2019s Hospital, Zhengzhou University People\u2019s Hospital)","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Oncology Department, The First Hospital of Dalian Medical University","place":["Dalian, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[{"name":"Oncology Department, The First Hospital of Dalian Medical University","place":["Dalian, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Yang","sequence":"additional","affiliation":[{"name":"Oncology Department, Henan University People\u2019s Hospital (Henan Provincial People\u2019s Hospital, Zhengzhou University People\u2019s Hospital)","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Tian","sequence":"additional","affiliation":[{"name":"Oncology Department, The First Hospital of Dalian Medical University","place":["Dalian, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linwei","family":"Li","sequence":"additional","affiliation":[{"name":"Oncology Department, Henan University People\u2019s Hospital (Henan Provincial People\u2019s Hospital, Zhengzhou University People\u2019s Hospital)","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.01490","article-title":"Clinical benefit of first-line programmed death-1 antibody plus chemotherapy in low programmed cell death ligand 1-expressing esophageal squamous cell carcinoma: A post hoc analysis of JUPITER-06 and meta-analysis","volume":"41","author":"Wu","year":"2023","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/jco.21.02500","article-title":"Esophagogastric cancers: Integrating immunotherapy therapy into current practice","volume":"40","author":"Patel","year":"2022","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.molp.2020.10.012","article-title":"Single-cell transcriptome analysis in plants: Advances and challenges","volume":"14","author":"Shaw","year":"2021","journal-title":"Mol Plant"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00447","article-title":"Changing technologies of RNA sequencing and their applications in clinical oncology","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-18-3882","article-title":"Differential variation analysis enables detection of tumor heterogeneity using single-cell RNA-sequencing data","volume":"79","author":"Davis-Marcisak","year":"2019","journal-title":"Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6268","DOI":"10.1038\/s41467-020-20019-0","article-title":"Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment","volume":"11","author":"Zheng","year":"2020","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2021.01.011","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1016\/j.cell.2022.09.020","article-title":"The primordial differentiation of tumor-specific memory CD8(+) T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes","volume":"185","author":"Huang","year":"2022","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.immuni.2022.02.005","article-title":"Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8(+) T cell responses","volume":"55","author":"Banta","year":"2022","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","first-page":"7335","DOI":"10.1038\/s41467-021-27599-5","article-title":"Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment","volume":"12","author":"Dinh","year":"2021","journal-title":"Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1038\/s41467-021-25539-x","article-title":"Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br J Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308531101","article-title":"Metagenes and molecular pattern discovery using matrix factorization","volume":"101","author":"Brunet","year":"2004","journal-title":"PNAS"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-024-01020-z","article-title":"Using clusterProfiler to characterize multiomics data","volume":"19","author":"Xu","year":"2024","journal-title":"Nat Protoc"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signaling"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409071102","article-title":"A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator","volume":"102","author":"Gonzalez","year":"2005","journal-title":"PNAS"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2023.5516","article-title":"Human leukocyte antigen and tumor immunotherapy (Review)","volume":"62","author":"Liu","year":"2023","journal-title":"Int J Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1172\/jci91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001195","article-title":"Subclass mapping: identifying common subtypes in independent disease data sets","volume":"2","author":"Hoshida","year":"2007","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Briefings Bioinf"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Sci (New York NY)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"V\u00f5sa","year":"2021","journal-title":"Nat Genet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1229","article-title":"The NHGRI GWAS Catalog, a curated resource of SNP-trait associations","volume":"42","author":"Welter","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1038\/s41467-019-12464-3","article-title":"Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease","volume":"10","author":"Szabo","year":"2019","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-01005-8","article-title":"Biallelic mutations in cancer genomes reveal local mutational determinants","volume":"54","author":"Demeulemeester","year":"2022","journal-title":"Nat Genet"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-00280-9","article-title":"Metabolic and epigenetic regulation of T-cell exhaustion","volume":"2","author":"Franco","year":"2020","journal-title":"Nat Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-022-00962-9","article-title":"Should mutant TP53 be targeted for cancer therapy","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Death Differ"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2023.2248376","article-title":"Update value and clinical application of MUC16 (cancer antigen 125)","volume":"27","author":"Song","year":"2023","journal-title":"Expert Opin Ther Targets"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2175-2","article-title":"Landscape and function of multiple mutations within individual oncogenes","volume":"582","author":"Saito","year":"2020","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1053\/j.gastro.2023.05.030","article-title":"Key genetic determinants driving esophageal squamous cell carcinoma initiation and immune evasion","volume":"165","author":"Ko","year":"2023","journal-title":"Gastroenterology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000005533","article-title":"Real-world evaluation of the efficacy of neoadjuvant DCF over CF in esophageal squamous cell carcinoma: Propensity score-matched analysis from 85 authorized institutes for esophageal cancer in Japan","volume":"278","author":"Matsuda","year":"2023","journal-title":"Ann Surg"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.03.008","article-title":"Advances and challenges in the treatment of esophageal cancer","volume":"11","author":"He","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.508","article-title":"Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial","volume":"34","author":"Tang","year":"2023","journal-title":"Ann Oncol Off J Eur Soc For Med Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104683","article-title":"Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer","volume":"153","author":"Deepak","year":"2020","journal-title":"Pharmacol Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nature21049","article-title":"Communication between viruses guides lysis-lysogeny decisions","volume":"541","author":"Erez","year":"2017","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jtho.2019.08.355","article-title":"Genomic and functional approaches to understanding cancer aneuploidy","volume":"33","author":"Taylor","year":"2018","journal-title":"Cancer Cell"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.695173","article-title":"Current status of chikungunya in India","volume":"12","author":"Jagadesh","year":"2021","journal-title":"Front Microbiol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/nature01148","article-title":"Rho GTPases in cell biology","volume":"420","author":"Etienne-Manneville","year":"2002","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msl145","article-title":"Evolution of the Rho family of ras-like GTPases in eukaryotes","volume":"24","author":"Boureux","year":"2007","journal-title":"Mol Biol Evol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/genes9020067","article-title":"RhoB: Team oncogene or team tumor suppressor","volume":"9","author":"Ju","year":"2018","journal-title":"Genes"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-03-0149","article-title":"Loss of RhoB expression in human lung cancer progression","volume":"10","author":"Mazieres","year":"2004","journal-title":"Clin Cancer Res: Off J Am Assoc For Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078417","article-title":"Expression loss and revivification of RhoB gene in ovary carcinoma carcinogenesis and development","volume":"8","author":"Liu","year":"2013","journal-title":"PloS One"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25445","article-title":"A distinct role of RhoB in gastric cancer suppression","volume":"128","author":"Zhou","year":"2011","journal-title":"Int J Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1080\/21541248.2016.1234429","article-title":"RHOB expression controls the activity of serine\/threonine protein phosphatase PP2A to modulate mesenchymal phenotype and invasion in non-small cell lung cancers","volume":"9","author":"Calvayrac","year":"2018","journal-title":"Small GTPases"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157599","article-title":"RhoB acts as a tumor suppressor that inhibits Malignancy of clear cell renal cell carcinoma","volume":"11","author":"Chen","year":"2016","journal-title":"PloS One"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.04.021","article-title":"The critical role of dysregulated RhoB signaling pathway in radioresistance of colorectal cancer","volume":"104","author":"Liu","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2023.01.007","article-title":"Tensor decomposition of largest convolutional eigenvalues reveals pathologic predictive power of RhoB in rectal cancer biopsy","volume":"193","author":"Pham","year":"2023","journal-title":"Am J Pathol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24617","article-title":"RhoB induces apoptosis via direct interaction with TNFAIP1 in HeLa cells","volume":"125","author":"Kim","year":"2009","journal-title":"Int J Cancer"},{"key":"B63","article-title":"Significant association of Rho\/ROCK pathway with invasion and metastasis of bladder cancer","volume":"9","author":"Kamai","year":"2003","journal-title":"Clin Cancer Res: Off J Am Assoc For Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2008.12","article-title":"In vivo restoration of RhoB expression leads to ovarian tumor regression","volume":"15","author":"Couderc","year":"2008","journal-title":"Cancer Gene Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1775837\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:37:51Z","timestamp":1774593471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1775837\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":64,"alternative-id":["10.3389\/fimmu.2026.1775837"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1775837","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"article-number":"1775837"}}